Mitogen-activated protein kinases (MAPK) as predictors of clinical outcome in serous ovarian carcinoma in effusions

By Miller Brigitte  

The Women's Oncology Review, Vol. 4, Iss. 1, 2004-01 ,pp. : 27-28

Informa Healthcare

Access to resources Recommend Favorite

Matrix metalloproteinases (MMP), EMMPRIN (extracellular matrix metalloproteinase inducer) and mitogen-activated protein kinases (MAPK): Co-expression in metastatic serous ovarian carcinoma

By Davidson Ben   Givant-Horwitz Vered   Lazarovici Philip   Risberg Björn   Nesland Jahn   Trope Claes   Schaefer Erik   Reich Reuven  

Clinical and Experimental Metastasis, Vol. 20, Iss. 7, 2003-11 ,pp. : 621-631

Springer Publishing Company

Access to resources Recommend Favorite

Micropapillary Serous Ovarian Carcinoma: Surgical Management and Clinical Outcome

By Bristow R.E.   Gossett D.R.   Shook D.R.   Zahurak M.L.   Tomacruz R.S.   Armstrong D.K.   Montz F.J.  

Gynecologic Oncology, Vol. 86, Iss. 2, 2002-08 ,pp. : 163-170

Academic Press

Access to resources Recommend Favorite

Interleukin-8 and vascular endothelial growth factor mRNA and protein levels are down-regulated in ovarian carcinoma cells in serous effusions

By Davidson Ben   Reich Reuven   Kopolovic Juri   Berner Aasmund   Nesland Jahn   Kristensen Gunnar   Tropé Claes   Bryne Magne   Risberg Bjørn   van de Putte Gregg   Goldberg Iris  

Clinical and Experimental Metastasis, Vol. 19, Iss. 2, 2002-03 ,pp. : 135-144

Springer Publishing Company

Access to resources Recommend Favorite

Nardostachys jatamansi inhibits severe acute pancreatitis via mitogen-activated protein kinases

By              

Experimental and Therapeutic Medicine, Vol. 4, Iss. 3, 2012-01 ,pp. : 533-537

Spandidos Publications

Access to resources Recommend Favorite